RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $18,329,000 | +94.9% | 495,113 | 0.0% | 0.12% | +126.4% |
Q2 2022 | $9,402,000 | -29.6% | 495,113 | 0.0% | 0.05% | -31.2% |
Q1 2022 | $13,363,000 | +19.8% | 495,113 | 0.0% | 0.08% | +42.6% |
Q4 2021 | $11,155,000 | +111.8% | 495,113 | +146.3% | 0.05% | +134.8% |
Q3 2021 | $5,268,000 | +114.8% | 200,996 | +162.4% | 0.02% | +109.1% |
Q2 2021 | $2,452,000 | – | 76,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |